At exposure concentrations of 750 ppm or more, acetaldehyde is a rodent inhalation carcinogen that induces nasal tumors. Aldehyde dehydrogenase (ALDH) is thought to be an important detoxifying enzyme for aldehydes. Although nasal tissues express ALDH, the importance of this enzyme relative to delivered dosage rates at high-inspired concentrations is not well defined. To provide such information, uptake of inspired acetaldehyde was measured at an inspiratory flow rate that approximated the minute ventilation rate in the surgically isolated nasal cavity of F 344 rats pretreated with either saline (control) or the ALDH inhibitor, cyanamide (10 mg/kg sc). ALDH activities (substrate concentration 3 times the K m ) in anterior (respiratory mucosa) and posterior (olfactory mucosa) nasal tissues averaged 160 and 210 nmol/min, respectively, in control animals (total activity 370 nmol/min), compared to 60 and 80 nmol/min, respectively, in cyanamidepretreated rats (p < 0.05), indicating that approximately 60% inhibition was obtained. Nasal uptake was measured at 3 inspired concentrations: 10, 300, and 1500 ppm. At these concentrations, acetaldehyde uptake efficiency averaged 54, 37, and 34% in salinepretreated rats, respectively (p < 0.05). In absolute terms, the delivered dosage rates at these exposure concentrations averaged 21, 420, and 1990 nmol/min. The concentration dependence on uptake suggests a saturable process was involved. At inspired concentrations of 300 ppm or more, the delivered dosage rates exceeded the measured specific activity for nasal ALDH of 370 nmol/min. Cyanamide pretreatment abolished the concentration dependence. Specifically, uptake efficiencies in cyanamide-pretreated rats averaged 30, 27, and 31% at inspired concentrations of 10, 300, and 1500 ppm, respectively (p > 0.05); delivered dosage rates were 12, 310, and 1780 nmol/min. Thus, cyanamide pretreatment reduced nasal-delivered dosage rates at inspired concentrations of 10, 300, and 1500 ppm, respectively by 9, 110, and 210 nmol/min, values that correspond well with the total nasal ALDH activity of 370 nmol/min. In toto, these results suggest that inspired acetaldehyde is metabolized in situ by ALDH, but at exposure concentrations of 300 ppm or greater, the delivered dosage rate may equal or exceed the capacity of this enzyme.
Acetaldehyde is a common indoor and outdoor air pollutant (Lofroth et al., 1989; Puxbaum et al., 1988) . It is produced during the combustion of wood and cigarettes and is one of the most prevalent aldehydes in tobacco smoke. Concentrations of this aldehyde in smoky rooms may reach 0.1 ppm (Badre et al., 1978) . Acetaldehyde is an important industrial chemical in the plastics, resin, and paper industries; its occupational exposure limit is 100 ppm and is based upon sensory irritation (OSHA, 1996) . The RD50 in the rat for sensory irritation is 3000 ppm (Babiuk et al., 1985) .
The inhalation toxicity of acetaldehyde has recently been reviewed (Feron et al., 1991; Morris 1997a) . Inhalation exposure of rodents to acetaldehyde results in injury to the upper airways. In the rat, nasal tissues are the target site, with the olfactory mucosa being more sensitive than the respiratory mucosa. For example, subchronic exposure of the rat to 400 ppm (6 hr/day, 5 days/wk, for 4 weeks) results in mild degeneration of the olfactory epithelium without apparent injury to the respiratory epithelium (Appelman et al., 1982) . Chronic exposure of the rat to 750 ppm results in nasal adenocarcinomas, presumably of olfactory origin, whereas exposure to 1500 ppm produces both adenocarcinomas and squamous cell carcinomas (presumably of respiratory mucosal origin) (Woutersen et al, 1984 . The reasons for the heightened sensitivity of the olfactory mucosa are not known.
Acetaldehyde is metabolized by aldehyde dehydrogenase (ALDH) (Lindahl, 1992) to the non-DNA-reactive acetic acid. This detoxication enzyme is expressed in nasal tissues of the rat and several other rodent species (Casanova-Schmitz et al., 1984; Bogdanffy et al., 1986; Morris, 1997b; Morris and Blanchard, 1992) . Lam et al (1986) have observed increased DNA-protein cross-link levels, as measured by a chloroformisoamyl alcohol extraction procedure, in nasal respiratory mucosa after a single 6-h exposure to 1000 or 3000 ppm acetaldehyde. Increased crosslink levels were not observed in olfactory tissues after single exposure but were observed after mutiple-day exposure. By analogy to formaldehyde, DNAprotein crosslink formation may be a biomarker for a delivered dose of reactive aldehyde to nasal nuclei, and may be mechanistically related to tumor formation (Heck et al., 1990) .
The upper respiratory tract dosimetry of acetaldehyde has been studied previously in this laboratory (Morris, 1997a; Morris and Blanchard, 1992) . In the rat, as well as the mouse, hamster, and guinea pig, reduced acetaldehyde uptake efficiencies were observed at exposure concentrations of 1000 ppm compared to 100, 10, or 1 ppm, suggesting that saturation was involved in the uptake process (Morris 1997b; Morris and Blanchard, 1992) . Since studies in our laboratory have shown that nasal metabolism serves to enhance uptake of substrate vapors for carboxylesterase (Morris, 1990; Morris and Frederick, 1995) , alcohol dehydrogenase or mixed function oxidase (Morris, 1993) , it was hypothesized that the enhanced uptake of acetaldehyde at low-exposure concentrations was due to metabolism by nasal aldehyde dehydrogenase. At high exposure concentrations, the metabolic capacity of this enzyme (as measured by whole tissue Vmax levels) was greatly exceeded, and the metabolism-dependent enhancement of uptake was lost. However, alternate explanations for the reduced uptake at high-exposure concentrations are possible, including a depletion of tissue substrates for direct chemical reaction with acetaldehyde and/or a nonspecific toxic effect in nasal tissues. The current study was designed to investigate whether inspired acetaldehyde was metabolized by aldehyde dehydrogenase in the F344 rat nose and whether this process could explain, in part, the reduced uptake observed at high-versus low-exposure concentrations. Towards this end, nasal uptake efficiencies were measured in animals pretreated with the aldehyde dehydrogenase inhibitor, cyanamide. These studies were performed at both high (1500 ppm) and lower (300 and 10 ppm) exposure concentrations, with the expectation that the enzyme inhibitor would decrease uptake efficiencies if metabolism did, in fact, serve to enhance uptake. Furthermore, the enzyme would abolish the concentration dependence on uptake, were it metabolically based. The effects of cyanamide on uptake of the non-metabolized vapor acetone were also studied to confirm that any effects of this inhibitor were specific to acetaldehyde rather than being generalized in nature. Finally, since it was anticipated that ALDH inhibition would alter the relationship between exposure concentration and delivery of reactive acetaldehyde to the nuclei, the current studies also included measurement of DNA-protein crosslink levels in respiratory mucosa of normal and cyanamide-pretreated rats. (Olfactory mucosa was not examined, because crosslinks had not been observed in this tissue following single exposure (Lam et al., 1986) . By including measures of both uptake and crosslink formation, it was anticipated that a comprehensive evaluation of nasal acetaldehyde dosimetry would be obtained.
MATERIALS AND METHODS
Animals and reagents. Specific pathogen-free male Fischer 344 rats (Charles River Laboratories, Wilmington, MA, VAF/Plus Crl:CDBR, aged 45-70 days, bw 170 -230 g) were used in all experiments. Animals were housed over hardwood bedding in animal rooms maintained at 22-25°C with a 12-h light-dark cycle (lights on at 6:30 A.M.). Animals were acclimated 1 week prior to use and were used within 4 weeks of arrival. Acetaldehyde (99% purity) was obtained from Aldrich Chemical (Milwaukee, WI). Cyanamide was obtained from Sigma Chemical (St. Louis, MO). All other reagents were obtained form local suppliers and were of the highest purity available.
Animal exposure and tissue collection protocols. Animals were pretreated with either saline (1 ml/kg) or cyanamide (10 mg/ml in saline, given in a volume of 1 ml/kg) via sc injection. For exposure and measurement of uptake, the upper respiratory tract (URT) was surgically isolated by the method used previously in this laboratory (Morris, 1990) . Briefly, animals were anesthetized with urethane (1.3 g/kg ip), the trachea was split and an endotracheal tube was inserted anteriorly so that the tip lay at the larynx. The animal was then placed in a nose-only chamber and chamber air was drawn through the isolated URT for 50 min under the flow conditions described below. Respiration rates were counted every 10 min, at which time the nasal air pressure drop was monitored via a differential pressure transducer (Validyne model DP-45-28) connected to a T-connector in the endotracheal tube. For 6-h inhalation exposure, non-anesthetized animals were placed in the same nose-only exposure chamber as used for uptake measurement. Animals were anesthetized with urethane (1.3 g/kg, ip) at the end of exposure and then exsanguinated.
The nasal cavity of each anesthetized, exsanguinated rat was lavaged once with 3 ml of saline via the endotracheal tube, and the saline was collected at the external nares. Average lavage recovery was greater than 2.5 ml. The lavage fluid was then spun at 600 g for 10 min to remove any debris, and a fresh aliquot of the supernatant was used for LDH measurement. The remaining lavage sample was treated with phenylmethylsulfonyl fluoride (PMSF, 2 l of a 0.05 M solution) and frozen for subsequent protein content analysis.
To collect tissues for ALDH determination, the skulls of urethane-anesthetized animals were split sagittally, and nasal tissue homogenates, primarily of respiratory (anterior) or olfactory (posterior) tissues, were prepared in cold Krebs-Ringer/EDTA buffer containing 0.1 mM dithiothreitol. The anterior tissue homogenate contained tissues from the nasoturbinates, maxilloturbinates, lateral walls, and the septum anterior to the olfactory epithelium. The posterior tissue homogenate contained tissues from the dorsal medial meatus, ethmoid turbinates, and the posterior septum. Final homogenate volumes were 8 ml. Homogenates were spun at 600 g for 10 min, and aliquots of the supernatant were spun at 10,000 g and stored on ice for measurement of ALDH activity as described below. The amount of protein in the homogenate averaged approximately 3 mg for the anterior and 6 mg for the posterior tissue homogenates.
For DNA-protein crosslink studies, unanesthetized animals pretreated with saline (1 ml/kg) or cyanamide (10 mg/ml in saline; 1 ml/kg) were exposed to chamber air or 1500 ppm acetaldehyde continuously for 6 h in the nose-only chamber. All injections were made 1 h prior to the onset of exposure. This exposure concentration was selected because significant increases in DPX occur at acetaldehyde concentrations of 1000 or higher (Lam et al., 1986) . After exposure, animals were anesthetized, lavaged, and tissue homogenates were prepared as described above, except that tissues were homogenized in phosphate-buffered saline (50 mM, pH 7.6) in a final volume of 5 ml.. Aliquots (900 ul) of the nasal tissue homogenate were treated with 100 l of sodium borohydride (100 mg in 10 ml of 0.01 N NaOH) and placed on ice for 30 min. Then 250 l of 10% SDS was added and the samples were frozen for subsequent analysis of DPX by the method of Zhitkovich and Costa (1992) .
Uptake measurement. To measure URT uptake, vapor laden air was drawn through the isolated URT of the rat at a unidirectional inspiratory flow rate of 100 ml/min. This flow rate has been previously used in our laboratory (Morris and Blanchard, 1992) and is within the physiological range of the rat. Vapor concentrations were measured in the air entering the URT (Cin) and the air exiting the URT (Cex). Cex was measured throughout the 50-min exposure period. For each animal, chamber air concentration (Cin) was measured immediately before and again immediately after Cex determination under the same flow conditions. The average value of these concentrations was used to determine percent uptake. The "before" and "after" chamber concentrations did not differ by greater than 2% over the entire study.
Air sampling. The sampling system used for drawing air samples consisted of a glass trap (6 ml) connected to 2 vacuum sources. Air is drawn off the trap (ϳ7 ml/min) and into a gas chromatograph (see below) via heated tubing. Air samples were injected into chromatograph every 3.0 min to provide continuous monitoring. Polyethylene tubing was used to connect the trap to the sampling port (Cin determination) or the animal endotracheal tube (Cex determination). Total airflow rate was maintained at the desired flow by a rotameter, which had been previously calibrated in the sample line.
Chamber conditions and vapor generation. All exposures were performed in a CH Technologies 24-port nose-only inhalation chamber. For the uptake studies, total air-flow rates through the chamber were maintained at 5 L/min with clean, filtered, humidified air. Chamber air temperature averaged 40°C. Chamber walls, inlet tubing, and sample tubing were heated to prevent condensation. A hot air gun was used to warm the animal and to minimize condensation in the endotracheal tubing.
Chamber concentrations were generated with a syringe pump system. Aqueous solutions of acetone or acetaldehyde (prepared daily) were fed into a 500-ml flask maintained at 60°C. Air (0.5 L/min) was passed through the flask into the chamber-diluting air line. Chamber concentrations were controlled by changing the solvent concentration in the aqueous generation fluid. The chamber was operated for at least 45 min prior to measurement of uptake, to allow for equilibration. Nominal acetaldehyde concentrations for this study were approximately 17,510 and 2500 g/L corresponding to 10,300 and 1500 ppm, respectively. The actual concentrations averaged 15.8 Ϯ 0.37, 518.8 Ϯ 100.9, and 2665.7 Ϯ 183.7 g/L. The effects of cyanamide on acetone uptake were also measured to confirm that the inhibitor did not produced generalized changes in the URT uptake process. Acetone concentrations for these measurements were approximately 80 ug/L.
For the 6 h exposures used in the DPX studies, animals were exposed either to chamber air or 1500 ppm acetaldehyde. Chamber concentrations for acetaldehyde were generated as described above with a total airflow of 3 L/min. Chamber temperature ranged between 23-25°C and relative humidity ranged between 41-49%. Acetaldehyde chamber concentrations were monitored continuously via the sampling system used for Cex determination (described above) and averaged 1600 Ϯ 120 ppm.
Analytical techniques. Vapor concentrations were measured in a Varian
Model 3600 gas chromatograph (GC) equipped with a flame ionization detector. A 15-m DB-Wax megabore column (J & W Scientific, Folsom, CA) was used with a column oven temperature of 33°C and a carrier gas (N 2 ) flow rate of 30 ml/min. For analysis, air was continuously passed through 1 of 2 sample loops in an 8-port gas sampling valve. Samples were injected on the column every 3.0 min to provide continuous monitoring. Peak areas (Varian Model 4290 integrator) were converted to concentrations on the basis of a standard curve by injecting 4-l aliquots of aqueous vapor standards into Teflon gas sampling bags (Cole-Palmer, Niles, IL), which were then filled with 0.8 liter of clean air. After at least 1 h, to allow for evaporation, air was drawn from the bags through the sample train used for uptake measurement and into the GC gas sampling valve for analysis.
Biochemical measurements. Supernatants of nasal tissue homogenates were analyzed for protein by the method of Lowry et al. (1951) using bovine serum albumin as a standard. Lavage fluid was analyzed for LDH activity by the method of Wahlefeld (1985) . Aliquots of nasal tissue homogenate, 10,000 g supernatant, were analyzed for ALDH activity. Aldehyde dehydrogenase activity was measured spectrophotometrically by quantitating acetaldehydedependent formation of NADH at 340 nM (Casanova-Schmitz et al., 1984) during 1-4 min after the addition of acetaldehyde. The total incubation volume was 1.0 ml. Final NAD concentration was 4 mM (Morris and Blanchard, 1992) and final acetaldehyde concentration was 60 mM (ϳ3 times the K m ) (Casanova-Schmitz et al., 1984) . The alcohol dehydrogenase inhibitor, 4-methylpyrazole, was included at a concentration of 0.75 mM. The NADH formation in the absence of acetaldehyde was used as a control and subtracted from the NADH formation rate measured in the presence of acetaldehyde. The formation of NADH was linear with both protein and time.
The formation of DNA-protein crosslinks in the respiratory epithelium was measured by the method of Zhitkovich and Costa (1992) , which is based upon SDS-KCL precipitation. Briefly, upon thawing, the NaBH 4 -SDS-treated homogenates were mixed and then sheared, by 7 passes of the sample, through a 17.5-gauge needle. After shearing, 100 l of 2.5 M KCL was added to each sample, placed on ice for 5 min, and then spun at 3000 g for 5 min. The supernatant was collected and the pellet was resuspended in 1ml of wash buffer (0.1 M KCL, 0.1mM EDTA, and 10 mM Tris-HCL), placed on ice for 5 min, and then spun at 3000 g for 5 min. This wash step was repeated 3 times, and the supernatant was collected and pooled for each sample. The final pellet was resuspended in 1 ml of wash buffer containing 100 g/ml proteinase K and incubated in a 37°C water bath for 4 h. The digested pellet and pooled fraction of supernatant were then stored overnight at 4°C for subsequent DNA analysis.
DNA content was determined fluorometrically (Model F-2000 Fluorescence Spectrophotometer, Hitachi, Ltd., Tokyo), in 250-l aliquots of the supernatants pooled from the washing steps and the resuspended pellet, by the addition of bisbenzimide (Labarca et al. 1980) . The concentration of DNA was determined using calf thymus DNA as a standard. The DNA content in the supernatants, from the washing steps, is considered to be "free" DNA, whereas the DNA content measured in the pellet is considered to be DNA bound (crosslinked) to protein. The percent DPX formed was calculated by dividing the bound DNA by the total DNA (bound plus free).
To confirm that the SDS-KCL precipitation method of Zhitkovich would be capable of detecting acetaldehyde-induced DPX in our laboratory, in vitro studies were performed as described by Lam et al (1986) . Briefly, whole nasal tissue homogenates were incubated with 0, 100, or 500 mM acetaldehyde for 20 min on ice. Then 100 uL of a sodium borohydride solution was added to each of the samples, and after a 30-min incubation on ice, the formation of DPX was determined by the method described above.
Mathematical analysis.
All data are presented as means Ϯ SD unless otherwise indicated. All statistical calculations were performed using Statistica software (Statsoft, Inc., Tulsa, OK), with p Ͻ 0.05 being required for significance.
RESULTS

Activity of ALDH in Nasal Tissue Homogenates
Shown in Figure 1 are the activities of aldehyde dehydrogenase, determined in separate anterior (respiratory) and posterior (olfactory) tissue homogenates. Animals were pretreated with saline or cyanamide 1 or 7 h prior to sacrifice. (The 7-h time was used to determine if cyanamide treatment 1 h prior to the onset of exposure would produce inhibition throughout a 6 h exposure period.) At an acetaldehyde concentration of 60 mM (3 times the K m ) (Casanova-Schmitz et al., 1984) , ALDH activity in saline-pretreated animals averaged 210 nmol/min and 160 nmol/min (64 and 28 nmol/min/mg protein) in respiratory and olfactory tissues, respectively. This rate corresponds to a total-nasal-tissue activity of 370 nmol/min. In animals pretreated with cyanamide for 1 or 7 h prior to sacrifice, ALDH activity averaged, respectively, 90 and 110 nmol/min (30 and 34 nmol/mg protein) in respiratory tissue and 100 and 90 nmol/min (17 and 16 nmol/mg protein) in olfactory tissue. Two-factor analysis of variance showed that cyanamide pretreatment significantly decreased the activity of ALDH by about 60% in both respiratory and olfactory tissues when compared to saline pretreated controls (p Ͻ 0.05). Similar levels of inhibition were observed in animals pretreated with cyanamide both 1 and 7 h prior to sacrifice (p Ͻ 0.05). No statistical interaction was observed.
Uptake Studies
In each animal, acetone uptake efficiencies remained constant for between 6 and 48 min of exposure. The average value over this period was used for subsequent calculations. Acetone uptake averaged 21.2 Ϯ 3.3 % in saline-pretreated animals compared to 25.0 Ϯ 2.2 % in cyanamide-pretreated animals. These groups were not statistically different (p Ͼ 0.
05, t-test).
In each animal, acetaldehyde uptake efficiencies remained constant for between 6 and 50 min of exposure. The average value for each animal was used for subsequent calculations. Figure 2 shows the effect of cyanamide pretreatment on acetaldehyde uptake. Two-factor analysis of variance revealed significant effects of cyanamide, of exposure concentration, and of interaction between cyanamide and exposure concentration. Uptake efficiency was approximately 2-fold higher in saline-pretreated animals at an inspired concentration of 10 ppm than at 300 or 1500 ppm (p Ͻ 0.05; Newman-Keuls test). Acetaldehyde-uptake efficiency averaged 30, 27, and 31% in cyanamide-pretreated animals at inspired concentrations of 10, 300, and 1500 ppm, respectively. These values were not significantly different (p Ͼ 0.05; Newman-Keuls test) indicating that cyanamide pretreatment abolished the concentration dependency for acetaldehyde uptake. Uptake efficiencies in cyanamide-pretreated animals were significantly lower than in saline-pretreated animals at inspired concentrations of 10 and 300 ppm, a significant difference between cyanamide-and saline-pretreated animals was not detected at an exposure concentration of 1500 ppm.
The effect of cyanamide on the delivered dosage rate of acetaldehyde (nmol/min) is presented in Table 1 . At exposure concentrations of 10 or 300 ppm, delivered-dosage rate was significantly lower in cyanamide-than in saline-pretreated animals (2-factor ANOVA, followed by Newman-Keuls test). On the average, dosage rates were 9 and 110 nmol/min lower in cyanamide-treated animals at these concentrations. At an inspired concentration of 1500 ppm, delivered-dosage rates were roughly 210 nmol/min lower in cyanamide-pretreated than in saline-pretreated animals, but a significant difference was not detected.
To confirm that the inhibition of ALDH by cyanamide was unaltered in vivo by subsequent exposure to acetaldehyde, ALDH activity was measured in the nasal homogenates from   FIG. 1 . Measurement of ALDH activity on anterior (respiratory mucosa) and posterior (olfactory mucosa) nasal tissue homogenates. Activity was measured at a substrate concentration of 60 mM acetaldehyde as described in Materials and Methods. Animals were pretreated with either saline or cyanamide (10 mg/kg sc) for 1 or 7 h prior to sacrifice. Data were analyzed by two-factor ANOVA. Pretreatment with cyanamide significantly decreased ALDH activity, but no significant differences were detected between length of pretreatment. No differences in ALDH activity were detected between nasal tissues. Asterisks above the bars indicate significant differences between saline and cyanamide pretreated animals (p Ͻ 0.05; Newman-Keuls test).
FIG. 2.
The effect of cyanamide pretreatment on acetaldehyde uptake. The percent uptake of acetaldehyde was measured in the isolated URT of animals pretreated with either saline or cyanamide. Uptake was measured at 3 exposure concentrations: 10, 300, and 1500 ppm. Data were analyzed by 2-factor ANOVA. Cyanamide had a significant effect on acetaldehyde uptake at 10 and 300 ppm, but not at 1500 ppm. There was a significant effect of exposure concentration on uptake in saline-pretreated animals at 300 versus 10 ppm, but not at 1500 ppm. Labels above bars represent comparisons between pretreatment and exposure concentrations; bars with differing letters are significantly different from each other (p Ͻ 0.05; Newman-Keuls test). Note. Delivered dosage rates were calculated from the inspiratory flow rate, the percent uptake normalized to inspired concentrations of 17, 510, and 2500 g/L, for the 10, 300, and 1500 ppm groups, respectively. Groups with differing superscripts ( a, b c, d, e ) are significantly different from each other (p Ͻ 0.05; 2-factor ANOVA, followed by Newman-Keuls test). Analysis was performed on log transformed data due to differences in variability among groups (Zar, 1984) . animals exposed to acetaldehyde. Exposure to acetaldehyde did not significantly affect the activity of ALDH. In saline pretreated animals, ALDH activity averaged 152 and 209 nmol/min in respiratory and olfactory tissues, respectively. In cyanamide pretreated animals, ALDH activity averaged 56 and 75 nmol/min/mg protein in respiratory and olfactory tissues, respectively. Thus, pretreatment with cyanamide significantly decreased the activity of ALDH by approximately 60% in both respiratory and olfactory tissues when compared to saline pretreated controls (p Ͻ 0.05, two-factor analysis of variance ). These data are consistent with the results obtained from animals that were not exposed to acetaldehyde (Fig. 1) . Figure 3 shows that incubation of nasal tissue homogenates with 500 mM acetaldehyde results in a significant increase in DPXs when compared with tissue homogenates incubated with 0 or 100 mM acetaldehyde, as indicated by two-factor analysis of variance (p Ͻ 0.05, followed by the Newman-Keuls test). Thus, this methodology is capable of detecting acetaldehydeinduced crosslinks. The formation of DPX in the RE was measured as a biomarker for delivery of acetaldehyde to nasal nuclei during the 6-h exposure to 1500 ppm acetaldehyde (Fig.  4) . Two-factor analysis of variance did not detect a significant effect of acetaldehyde, nor cyanamide, nor an interaction (p Ͼ 0.05). Thus, an increased DPX was not detected in either saline or cyanamide-pretreated rats. Nasal lavage protein and lavage LDH content was similar in control and acetaldehyde exposed rats (p Ͼ 0.05).
Measurement of DNA-Protein Crosslinks in Respiratory Epithelium
DISCUSSION
Acetaldehyde is metabolized to acetic acid via aldehyde dehydrogenase (Lindahl, 1992) . Casanova-Schmitz et al (1984) have documented the presence of ALDH activity in the nasal tissues of the F344 rat, and our laboratory has demonstrated ALDH activity in nasal tissues of the mouse, hamster, and guinea pig (Morris 1997b) . Although roughly equivalent total ALDH activities were observed in olfactory and respiratory mucosa homogenates in the current study (expressed as nmol/min), the specific activity (expressed by mg protein) was significantly greater in respiratory than olfactory tissue, a result that confirms the observations of Casanova-Schmitz et al. (1984) . Cyanamide is a long-acting, irreversible inhibitor of hepatic ALDH (Deitrich et al., 1976) . The current results indicate that single subcutaneous administration results in inhibition of nasal aldehyde dehydrogenase for at least 7 h. Similar degrees of inhibition were observed in non-exposed as well as air-or acetaldehyde-exposed rats. Thus, cyanamide may be a useful tool to examine the nasal disposition and/or toxicity of inhaled acetaldehyde.
Cyanamide pretreatment significantly reduced acetaldehyde uptake at inspired concentrations of 10 or 300 ppm, but was without effect on nasal acetone uptake. Acetone is a nonreactive, non-metabolized vapor whose uptake is dependent on nasal blood flow (Morris and Cavanagh, 1986; Morris et al., 1993) . These results suggest cyanamide does not exert generalized effects on the nasal uptake process. Therefore, the ef -FIG. 4 . The percent of DNA-protein crosslinks formed in vivo in the anterior, respiratory mucosa. Both saline and cyanamide pretreated animals were exposed, nose-only, to chamber air or 1500 ppm acetaldehyde for 6 h. The percent of DNA bound to protein was measured in respiratory epithelium tissue homogenates by the method of Zhitkovich et al. (1992) . Data were analyzed by two-factor ANOVA. No significant differences were observed between pretreatment or exposure groups.
FIG. 3.
The formation of DNA-protein crosslinks (DPX) in vitro on whole nasal tissue homogenates. Aliquots of whole nasal tissue homogenates were incubated with buffer, 100, or 500 mM acetaldehyde for 20 min. The formation of DPX was measured by the method of Zhitkovich and Costa. (1992) as described in Materials and Methods. Data was analyzed by ANOVA, followed by Newman-Keuls test. There was a significant increase in the percentage of DPX in homogenates incubated with 500 mM (*) compared to homogenates incubated with either buffer or 100 mM acetaldehyde (p Ͻ 0.05; Newman-Keuls test).
fects of cyanamide on acetaldehyde uptake can most likely be attributed to its inhibition of ALDH. Comparison of the in vitro ALDH data with the uptake data supports this conclusion. Specifically, cyanamide pretreatment diminished uptake by 9, 110, and 210 nmol/min at inspired concentrations of 100, 300, and 1500 ppm, a result fully consistent with the total nasal activity of 370 nmol/min. Although it is possible that cyanamide exerted its effects via unanticipated mechanisms, the fact that it selectively reduced uptake of acetaldehyde (but not acetone), and that it did so by a degree consistent with in vitro acetaldehyde metabolism data, strongly suggests that inspired acetaldehyde is metabolized in situ in the nose, and that this process serves to enhance nasal uptake.
The current study also confirms the concentration-dependence on nasal acetaldehyde uptake that was observed in our previous study (Morris and Blanchard, 1992) , with uptake being significantly more efficient at an inspired concentration of 10 compared to 300 or 1500 ppm. It was hypothesized that the concentration dependence was due to capacity limitation of acetaldehyde metabolism at high-inspired concentrations (Morris, 1997b; Morris and Blanchard, 1992) . The current results support this hypothesis. Cyanamide abolished the concentration dependence on uptake, providing strong evidence that this phenomenon is metabolically based. Statistically significant inhibition of uptake was observed at inspired concentrations of 10 or 300 ppm but not at 1500 ppm. At the later concentration, uptake rates averaged roughly 2000 nmol/min compared to the total nasal ALDH activity of 370 nmol/min. The lack of a statistical effect at 1500 ppm does not indicate that acetaldehyde was not metabolized at that inspired concentration, but that other uptake mechanisms predominated under these exposure conditions. Indeed, although not statistically significant, the magnitude of the cyanamide-induced change in uptake (210 nmol/min) at 1500 ppm was, in fact, greater than that observed at either 10 or 300 ppm (9 or 110 nmol/min). At 1500 ppm, acetaldehyde uptake may be dominated by removal via the bloodstream and/or by direct chemical reaction with tissue substrates. Acetaldehyde reacts with sulfhydryl and amino groups.
An increase in nasal DNA-protein crosslink formation in respiratory mucosa by a single 6-h exposure to 1500 ppm acetaldehyde was not observed in the current study. This exposure concentration was not overtly toxic, as evidenced by a lack of change in nasal lavage protein and LDH content. Histopathological studies also indicate acute acetaldehyde exposure is without overt effect (Cassee et al., 1996) . Lam et al (1986) detected an increase in crosslinks in this tissue after a single 6-h exposure to 1000 ppm acetaldehyde. The reasons for our failure to reproduce this observation are not clear. The current study utilized KCl-SDS precipitation to detect crosslinks, whereas Lam et al (1986) utilized chloroformisoamyl alcohol-phenol extraction. The discrepancy does not, however appear to reflect the inability of the KCl-SDS technique to detect acetaldehyde-induced crosslinks, because such were observed in vitro (Fig. 3) . Further studies are needed to clarify this issue. Such studies might best rely on chemical means of detecting crosslink formation, as has been done for formaldehyde (Casanova-Schmitz et al., 1984b; Heck et al., 1990) rather than physical (e.g. extraction, KCl-SDS precipitation) means.
Nasal metabolism is thought to enhance nasal uptake of substrate vapors for carboxylesterase (Morris, 1990, Morris and Frederick, 1995) , alcohol dehydrogenase or mixed function oxidase (Morris, 1993) . Thus the current results are consistent with those observed for vapors and extends this phenomenon to ALDH. The current studies relied on a single unidirectional inspiratory flow rate. Our previous studies have shown that the concentration dependence, which was observed on nasal acetaldehyde uptake, was quantitatively similar under unidirectional and cyclic flow conditions (Morris and Blanchard, 1992 ). In addition, we have previously shown that the effects of metabolic inhibition on reactive ester vapor uptake are similar under unidirectional versus cyclic flow conditions (Morris and Frederick, 1995) . Thus, it is very unlikely that the phenomena observed in the current study are specific to unidirectional flow regimes.
The absolute magnitude of the influence of nasal ALDH on acetaldehyde uptake in normally-breathing animals is not known, nor can it be quantitated precisely, because measurement of nasal uptake requires anesthesia and/or invasive methodologies that may quantitatively alter the uptake process. However, the current studies suggest that inspired acetaldehyde is, in fact, metabolized by nasal ALDH, and even if only crudely approximated, the current results suggest that nasaldelivered dosage rates at exposure concentrations of 750 ppm or more (which produce nasal tumors in the rat) greatly exceed the capacity of the nasal mucosa to detoxify this DNA-reactive aldehyde. Thus, direct extrapolation of data from inhalationtoxicity studies performed at such high-exposure concentrations in order to predict toxic effects at ambient exposure levels of 0.1 ppm or lower, may be problematic.
